Archives for May 15, 2006

← 2006

Bespak adds new asthma inhaler to its belt

By  Kirsty Barnes

Bang & Olufsen Medicom has joined with specialist device manufacturer Bespak to co-develop and co-market a new single increment dose counting inhaler for the expanding asthma and COPD (chronic obstructive pulmonary disease) market.

Gilson reinforces HPLC position at Analytica

By  Wai Lang Chu

Lab equipment specialists Gilson, were present at Analytica 2006, with a whole host of products designed for research and analytical preparations. The company attend the show with a view to strengthen its foothold in the burgeoning HPLC market.

PRA struggles after major contract woes

By Kirsty Barnes

As PRA International's profits tumble on the back of a major contract loss, coupled with ongoing delays in its biotech contracts, the company has introduced new project efficiency measures and is focusing on increasing its international presence.

Aspen to get lion's share in African Tamiflu production

By  Gregory Roumeliotis

Under pressure to ensure cheap supplies of its flu drug in Africa in preparation for a possible avian influenza, Roche has asked contract manufacturer Aspen Pharmacare to produce finished doses of Tamiflu (oseltamivir) in Africa.

GlycoFi proves too sweet for Merck to resist

By  Gregory Roumeliotis

Looking to make protein-based drugs faster and cheaper, Merck & Co has acquired biotechnology company GlycoFi for approximately $400m (€312m) in cash.

Greenhouse gas trading data show pharma overall within limits

By  Gregory Roumeliotis and Ahmed ElAmin

Preliminary data from the first year of the EU's greenhouse gas trading scheme has highlighted disparities in the allocation of plant outputs and in the tracking of carbon dioxide (CO2) emissions, yet, all in all, pharma has stayed within its allowances.